Dr. Christina Q. Payne, MD

Dr. Payne practices at Scripps Clinic Medical Group in San Diego, California.

Dr. Payne's NPI, 1679912661, was assigned on June 23, 2013. Dr. Payne holds Pennsylvania license MD462667.

Dr. Payne's primary practice is Scripps Clinic Medical Group, at 7565 Mission Valley Rd, San Diego, CA 92108 in San Diego County. The practice phone is (619) 245-2350.

Dr. Payne's primary practice is Scripps Clinic Medical Group in San Diego, California. Dr. Payne is also affiliated with Scripps Mercy Hospital San Diego. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Payne to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Payne practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Payne's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Payne is licensed in Pennsylvania.

CMS data shows 297 Medicare services from Dr. Payne across 5 procedure codes in 2024, for 135 Medicare patients. Medicare paid $25,065 for them. Every service was in an office.

CMS counts 135 Medicare patients who saw Dr. Payne in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Payne's median patient age at 57, with 70% women.

In 2024, Dr. Payne wrote 1,083 Medicare Part D claims for 174 patients. 86% of them were for generic drugs. CMS names the drug for 961 of them, across 25 drugs with 11 or more claims each, at $735,805 in total drug cost. In 2023, CMS named 733 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Payne for performance year 2024, reported through an alternative payment model (APM). Dr. Payne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Payne as offering telehealth.

CMS Open Payments shows 332 general payments to Dr. Payne from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Amgen Inc. paid the most, $26,480. It also lists 2 research payments totaling $117 in 2017.